Merck News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

30.10.19	It's 9-7 For Withdrawal Of Makena, Roche-Spark Deal Delayed Again, MRK On Watch (RTTNews)
29.10.19	Merck Raises 2019 Non-GAAP EPS Guidance Range - Quick Facts (RTTNews)
29.10.19	Merck & Co Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
28.10.19	European Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Patients With Advanced Renal Cell Carcinoma (PR Newswire)
02.10.19	Merck: FDA To Review Two Applications For DIFICID - Quick Facts (RTTNews)
30.09.19	AstraZeneca, MSD Report Positive Results From Phase III Trial With Lynparza (RTTNews)
27.09.19	New Data for BAVENCIO® (avelumab) for Advanced Cancers to Be Presented at ESMO 2019 (PR Newswire)
23.09.19	New Data at ESMO 2019 for Merck Highlight Focused Clinical Development and Commitment to Patient Care (PR Newswire)
20.09.19	CHMP Adopts Positive Opinion for BAVENCIO® (avelumab) Plus Axitinib for First-Line Treatment of Patients with Advanced Renal Cell Carcinoma (PR Newswire)
20.09.19	FDA Approves Merck's SNDAs For PIFELTRO And DELSTRIGO - Quick Facts (RTTNews)
18.09.19	FDA, Canada, Australia Collaborate On Cancer Drugs Review (RTTNews)
18.09.19	FDA Makes 1st Approval Under Project Orbis, KDMN On Watch, TBIO Down After-hrs (RTTNews)
17.09.19	Merck: FDA Grants Priority Review For Investigational Ebola Vaccine (RTTNews)
11.09.19	Merck Announces FDA Breakthrough Therapy Designation for Investigational Therapy Tepotinib in Patients with Metastatic NSCLC with METex14 Skipping Alterations (PR Newswire)
09.09.19	Updated Results for Investigational Therapy Tepotinib Presented at WCLC 2019 (PR Newswire)
04.09.19	Merck: European Commission Approves KEYTRUDA, Inlyta Combination To Treat RCC (RTTNews)
14.08.19	AstraZeneca Reports Breakthrough Therapy Designation For Calquence - Quick Facts (RTTNews)
07.08.19	AstraZeneca, Merck Report Positive Phase III Trial Results Of Lynparza (RTTNews)
31.07.19	Merck Says FDA Okays New Monotherapy Indication For KEYTRUDA (RTTNews)
30.07.19	Merck Lifts FY Adj. Profit View (RTTNews)
30.07.19	Merck & Co Inc. Q2 adjusted earnings Beat Estimates (RTTNews)
29.07.19	Merck: CHMP Supports KEYTRUDA Plus Inlyta To Treat Advanced Renal Cell Carcinoma (RTTNews)
26.07.19	Notable Earnings To Watch Next Week - LLY, AAPL, PG, MRK, PFE, CVX (RTTNews)
18.07.19	FDA Nod For MRK's Antibiotic; DRRX Awaits Big Day In Dec., Airxpanders Goes Bust (RTTNews)
17.07.19	Merck: FDA Approves Recarbrio - Quick Facts (RTTNews)
09.07.19	Merck Files Six SBLAs To Update Dosing Frequency For KEYTRUDA - Quick Facts (RTTNews)
26.06.19	Biotech Stocks Facing FDA Decision In July 2019 (RTTNews)
20.06.19	Merck Plans Strong Growth Over Next Five Years - Quick Facts (RTTNews)
19.06.19	AstraZeneca Receives Japanese Approval For Lung Disease Treatment (RTTNews)
18.06.19	Merck Reports First Approval For KEYTRUDA In Small Cell Lung Cancer (RTTNews)
18.06.19	AstraZeneca: EC Oks Lynparza As Maintenance Treatment For Ovarian Cancer (RTTNews)
13.06.19	IBM, KPMG, Merck And Walmart Collaborate For Drug Supply Chain Blockchain Pilot (RTTNews)
11.06.19	Merck Announces FDA Approval Of Two New Indications For KEYTRUDA - Quick Facts (RTTNews)
10.06.19	Merck To Acquire Tilos Therapeutics In Up To $773 Mln Deal - Quick Facts (RTTNews)
03.06.19	Merck Presents Updated Results for Investigational Therapy Tepotinib Demonstrating Durable Clinical Response in Patients with Advanced NSCLC with METex14 Skipping Mutations (PR Newswire)
25.05.19	Biotech Stocks Facing FDA Decision In June 2019 (RTTNews)
21.05.19	Merck To Acquire Peloton - Quick Facts (RTTNews)
21.05.19	Merck's Keytruda Fails Late Stage Clinical Trial (RTTNews)
07.05.19	Merck: Phase 3 Trial Of BELSOMRA C-IV Meets Primary Efficacy Endpoints (RTTNews)
30.04.19	Merck & Co Inc. Q1 adjusted earnings Beat Estimates (RTTNews)
29.04.19	AstraZeneca: Lynparza Receives Positive CHMP Opinion For Expanded Indication (RTTNews)
22.04.19	Merck: FDA Approves KEYTRUDA-Inlyta Combination - Quick Facts (RTTNews)
10.04.19	AstraZeneca: EU Spproves Lynparza As Monotherapy For Germline BRCA1/2-mutations (RTTNews)
05.04.19	Endo Unit Begins Shipping Generic Version Of Merck's PROVENTIL - Quick Facts (RTTNews)
02.04.19	Merck Reports Successful Completion Of Cash Tender Offer For Immune Design (RTTNews)
01.04.19	Merck Announces Post-hoc Analysis From KEYNOTE-189 Trial - Quick Facts (RTTNews)
01.04.19	AstraZeneca: Selumetinib Gets US Breakthrough Therapy Designation (RTTNews)
26.03.19	Biotech Stocks Facing FDA Decision In April (RTTNews)
20.03.19	Merck To Invest EUR 1 Bln Until 2025 At Darmstadt Site - Quick Facts (RTTNews)
20.03.19	Merck, NGM Bio Extend Broad, Strategic Collaboration To March 2022 (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

19.11.24		Schwacher Handel: Dow Jones beendet den Dienstagshandel mit Verlusten
19.11.24		Gute Stimmung in New York: NASDAQ 100 letztendlich im Plus
19.11.24		Schwacher Handel: Dow Jones legt am Dienstagnachmittag den Rückwärtsgang ein
19.11.24		Gewinne in New York: NASDAQ 100 legt zu
19.11.24		Dow Jones-Handel aktuell: So entwickelt sich der Dow Jones aktuell
19.11.24		Schwache Performance in Europa: Euro STOXX 50 zeigt sich zum Handelsende schwächer
19.11.24		Angespannte Stimmung in Europa: STOXX 50 verliert schlussendlich

19.11.24

Schwacher Handel: Dow Jones beendet den Dienstagshandel mit Verlusten

19.11.24

Gute Stimmung in New York: NASDAQ 100 letztendlich im Plus

19.11.24

Schwacher Handel: Dow Jones legt am Dienstagnachmittag den Rückwärtsgang ein

19.11.24

Gewinne in New York: NASDAQ 100 legt zu

19.11.24

Dow Jones-Handel aktuell: So entwickelt sich der Dow Jones aktuell

19.11.24

Schwache Performance in Europa: Euro STOXX 50 zeigt sich zum Handelsende schwächer

19.11.24

Angespannte Stimmung in Europa: STOXX 50 verliert schlussendlich

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Givaudan	3’870.00	1.49 %	K V
Lonza Grp	513.60	1.14 %	K V
Swiss Re	125.25	0.20 %	K V
Holcim	88.46	0.11 %	K V
Kuehne+Nagel Int	210.40	0.00 %	K V
Logitech Intl	68.92	-1.20 %	K V
Part Grp Hldg	1’209.00	-1.47 %	K V
CieFinRichemont	118.90	-1.94 %	K V
Nestle	76.66	-1.94 %	K V
Sonova Hldg	300.40	-5.21 %	K V

Nachrichten zu Merck Co.

Aktien Top/Flop

Merck Peer Group Nachrichten

Meistgelesene Nachrichten